Insider Trading Activity For Nabriva Therapeutics PLC – (NASDAQ:NBRV)
Colin Md Broom , CEO of Nabriva Therapeutics PLC – (NASDAQ:NBRV) reportedly Bought 5,000 shares of the company’s stock at an average price of 3.72 for a total transaction amount of $18,600.00 SEC Form
Recent Trading Activity for Nabriva Therapeutics PLC – (NASDAQ:NBRV)
Shares of Nabriva Therapeutics PLC – closed the previous trading session at with 3.630000114440918 shares trading hands.